✦ LIBER ✦

Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin

✍ Scribed by Daniel D. Gretler

Book ID: 117321489
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 87 KB
Volume: 25
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(03)80317-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective evaluation of bone density i

Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium

✍ Holly L. Casele; Steven A. Laifer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Objective: To evaluate changes in bone density in women receiving enoxaparin sodium during pregnancy. Methods: Bone density in the proximal femur was serially measured in 16 women receiving enoxaparin sodium (40 mg daily) during pregnancy. Baseline measurements were taken within 2 weeks of starting

The platelet proaggregating and potentia

The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls

✍ J. K. Burgess; Dr. B. H. Chong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

Biomarkers and Coagulation Tests for Ass

Biomarkers and Coagulation Tests for Assessing the Biosimilarity of a Generic Low-Molecular-Weight Heparin: Results of a Study in Healthy Subjects With Enoxaparin

✍ Kuczka, Karina; Harder, Sebastian; Picard-Willems, Bettina; Warnke, André; Donat 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 165 KB

Influence of thromboembolism prophylaxis

Influence of thromboembolism prophylaxis by low molecular weight heparin CY 216 (fraxiparine®) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216

✍ J. Diéval; P. Morinière; S. Gross; P. d'Azemar; A. Fournier; J. Delobel 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Efficacy and safety of tenecteplase in c

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT) 3 plus randomized trial in acute myocardial infarction

✍ L. Wallentin; P. Goldstein; P.W. Armstrong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB

A comparison of low-molecular-weight hep

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, et al. for the Efficacy and Safety of Subcutaneous Enoxaparin in NonQ-Wave Coronary Events Study Group. N Engl J Med 1997;337:447–452

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 86 KB